[Hy BioPharma Inc.] Also see "Hy BioPharma Inc." - Scrip, 1 July, 2008. is developing hypericin phototherapeutics for cancers and autoimmune disorders. The Israeli/US start-up is also in Phase I/IIb trials for an oral formulation of hypericin for possible use in combination therapy with Temodar for the treatment of glioblastoma.
MedGenesis Therapeutix Inc. Also see "MedGenesis Therapeutix Inc." - Scrip, 1 July, 2008. is developing convection-enhanced delivery, a technique that involves infusion under positive pressure of a drug...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?